Alzheimer's brains show lower levels of key protein, opening new diagnostic path

Researchers found that ADAM10, a protein involved in Alzheimer's disease progression, is significantly reduced in the brains and cerebrospinal fluid of patients with the disease. The discovery could enable earlier detection and help drug developers target this specific mechanism, potentially offering a biological marker for diagnosis before symptoms become severe.

Originaltitel: Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer's disease patients.